Conflicting and New Risk Factors for Contrast Induced Nephropathy

Journal of Urology

Volumn 178, Issue 6, 2007, Pages 2277-2283

  Toprak, Omer ^a  

^a ATATURK TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

contrast media; kidney; kidney failure; risk factors

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IODINATED CONTRAST MEDIUM; IODIXANOL; IOHEXOL; IOPAMIDOL;

CONTRAST INDUCED NEPHROPATHY; DIABETES MELLITUS; HIGH RISK PATIENT; HUMAN; HYPERTRIGLYCERIDEMIA; HYPERURICEMIA; HYPOVOLEMIA; IMPAIRED GLUCOSE TOLERANCE; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; LIVER CIRRHOSIS; METABOLIC SYNDROME X; MULTIPLE MYELOMA; OSMOLARITY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE;

CONTRAST MEDIA; DISEASE PROGRESSION; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; KIDNEY FAILURE, ACUTE; KIDNEY FUNCTION TESTS; MALE; PRIMARY PREVENTION; RISK FACTORS; SENSITIVITY AND SPECIFICITY; UROGRAPHY; UROLOGIC DISEASES;

EID: 35748940592     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2007.08.054     Document Type: Review

References (50)

1. Tepel M., Aspelin P., and Lameire N. Contrast-induced nephropathy: a clinical and evidence-based approach. Circulation 113 (2006) 1799
2. McCullough P. Outcomes of contrast-induced nephropathy: experience in patients undergoing cardiovascular intervention. Catheter Cardiovasc Interv 67 (2006) 335
3. Morcos S.K., Thomsen H.S., and European Society of Urogenital Radiology. European Society of Urogenital Radiology guidelines on administering contrast media. Abdom Imaging 28 (2003) 187
4. Rich M.W., and Crecelius C.A. Incidence, risk factors, and clinical course of acute renal insufficiency after cardiac catheterization in patients 70 years of age or older. A prospective study. Arch Intern Med 150 (1990) 1237
5. Rihal C.S., Textor S.C., Grill D.E., Berger P.B., Ting H.H., Best P.J., et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 105 (2002) 2259
6. Toprak O., and Cirit M. Risk factors for contrast-induced nephropathy. Kidney Blood Press Res 29 (2006) 84
7. McCarthy C.S., and Becker J.A. Multiple myeloma and contrast media. Radiology 183 (1992) 519
8. Persson P.B., Hansell P., and Liss P. Pathophysiology of contrast medium-induced nephropathy. Kidney Int 68 (2005) 14
9. Mehran R., Aymong E.D., Nikolsky E., Lasic Z., Iakovou I., Fahy M., et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol 44 (2004) 1393
10. Caldicott W.J., Hollenberg N.K., and Abrams H.L. Characteristics of response of renal vascular bed to contrast media. Evidence for vasoconstriction induced by renin-angiotensin system. Invest Radiol 5 (1970) 539
11. Workman R.J., Shaff M.I., Jackson R.V., Diggs J., Frazer M.G., and Briscoe C. Relationship of renal hemodynamic and functional changes following intravascular contrast to the renin-angiotensin system and renal prostacyclin in the dog. Invest Radiol 18 (1983) 160
12. Gupta R.K., Kapoor A., Tewari S., Sinha N., and Sharma R.K. Captopril for preventing of contrast-induced nephropathy in diabetic patients: a randomized study. Indian Heart J 51 (1999) 521
13. Dangas G., Iakovou I., Nikolsky E., Aymong E.D., Mintz G.S., Kipshidze N.N., et al. Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables. Am J Cardiol 95 (2005) 13
14. Toprak O., Cirit M., Bayata S., Yesil M., and Aslan S.L. The effect of pre-procedural captopril on contrast-induced nephropathy in patients who underwent coronary angiography. Anadolu Kardiyol Derg 3 (2003) 98
15. Cirit M., Toprak O., Yesil M., Bayata S., Postaci N., Pupim L., et al. Angiotensin-converting enzyme inhibitors as a risk factor for contrast-induced nephropathy. Nephron Clin Pract 104 (2006) c20
16. Toprak O., Cirit M., Yesil M., Bayata S., Tanrisev M., Varol U., et al. Impact of diabetic and pre-diabetic state on development of contrast-induced nephropathy in patients with chronic kidney disease. Nephrol Dial Transplant 22 (2007) 819
17. Xiong X.L., Jia R.H., Yang D.P., and Ding G.H. Irbesartan attenuates contrast media-induced NRK-52E cells apoptosis. Pharmacol Res 54 (2006) 253
18. Parfrey P.S., Griffiths S.M., Barrett B.J., Paul M.D., Genge M., Withers J., et al. Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. A prospective controlled study. N Engl J Med 320 (1989) 143
19. Nikolsky E., Mehran R., Turcot D., Aymong E.D., Mintz G.S., Lasic Z., et al. Impact of chronic kidney disease on prognosis of patients with diabetes mellitus treated with percutaneous coronary intervention. Am J Cardiol 94 (2004) 300
20. Lautin E.M., Freeman N.J., Schoenfeld A.H., Bakal C.W., Haramati N., Friedman A.C., et al. Radiocontrast-associated renal dysfunction: incidence and risk factors. AJR Am J Roentgenol 157 (1991) 49
21. Lindsay J., Apple S., Pinnow E.E., Gevorkian N., Gruberg L., Satler L.F., et al. Percutaneous coronary intervention-associated nephropathy foreshadows increased risk of late adverse events in patients with normal baseline serum creatinine. Catheter Cardiovasc Interv 59 (2003) 338
22. Aspelin P., Aubry P., Fransson S.G., Strasser R., Willenbrock R., and Berg K.J. Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med 348 (2003) 491
23. Chalmers N., and Jackson R.W. Comparison of iodixanol and iohexol in renal impairment. Br J Radiol 72 (1999) 701
24. McCullough P.A., Bertrand M.E., Brinker J.A., and Stacul F. A meta-analysis of the renal safety of isosmolar iodixanol compared with low-osmolar contrast media. J Am Coll Cardiol 48 (2006) 692
25. Baker C.S., Wragg A., Kuna S., DePalma R., Baker L.R., and Knight C.J. A rapid protocol for the prevention of contrast-inducted renal dysfunction: the RAPPID Study. J Am Coll Cardiol 41 (2003) 2114
26. Stone G.W., McCullough P.A., Tumlin J.A., Lepor N.E., Madyoon H., Murray P., et al. Fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomized controlled trial. JAMA 290 (2003) 2284
27. Barrett B.J., Katzberg R.W., Thomsen H.S., Chen N., Sahani D., Soulez G., et al. Contrast-induced nephropathy in patients with chronic kidney disease undergoing computed tomography: a double-blind comparison of iodixanol and iopamidol. Invest Radiol 41 (2006) 815
28. Liss P., Persson P.B., Hansell P., and Lagerqvist B. Renal failure in 57,925 patients undergoing coronary procedures using iso-osmolar or low-osmolar contrast media. Kidney Int 70 (2006) 1811
29. Holland M.D., Galla J.H., Sanders P.W., and Luke R.G. Effect of urinary pH and diatrizoate on Bence Jones protein nephrotoxicity in the rat. Kidney Int 27 (1985) 46
30. Mueller C., Buerkle G., Buettner H.J., Petersen J., Perruchoud A.P., Eriksson U., et al. Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Intern Med 162 (2002) 329
31. Iakovou I., Dangas G., Mehran R., Lansky A.J., Ashby D.T., Fahy M., et al. Impact of gender on the incidence and outcome of contrast-induced nephropathy after percutaneous coronary intervention. J Invasive Cardiol 15 (2003) 18
32. Mueller C., Buerkle G., Perruchoud A.P., and Buettner H.J. Female sex and risk of contrast nephropathy after percutaneous coronary intervention. Can J Cardiol 20 (2004) 505
33. Swartz R.D., Rubin J.E., Leeming B.W., and Silva P. Renal failure following major angiography. Am J Med 65 (1978) 31
34. Najjar M., Hamad A., Salameh M., Agarwal A., and Feinfeld D.A. The risk of radiocontrast nephropathy in patients with cirrhosis. Ren Fail 24 (2002) 11
35. Guevara M., Fernandez-Esparrach G., Alessandria C., Torre A., Terra C., Montana X., et al. Effects of contrast media on renal function in patients with cirrhosis: a prospective study. Hepatology 40 (2004) 646
36. Ahuja T.S., Niaz N., and Agraharkar M. Contrast-induced nephrotoxicity in renal allograft recipients. Clin Nephrol 54 (2000) 11
37. Elicker B.M., Cypel Y.S., and Weinreb J.C. IV contrast administration for CT: a survey of practices for the screening and prevention of contrast nephropathy. AJR Am J Roentgenol 186 (2006) 1651
38. Deray G., Mouquet C., Ourhama S., Bellin M.F., Jacquiaud C., Luciani J., et al. Effects on renal haemodynamics and tubular function of the contrast medium Ioxaglate in renal transplant patients. Clin Radiol 50 (1995) 476
39. Vigneau C., Fulgencio J.P., Godier A., Chalem Y., ElMetaoua S., Rondeau E., et al. The use of contrast media in deceased kidney donors does not affect initial graft function or graft survival. Kidney Int 70 (2006) 1149
40. Hietala S.O., Segerstedt B., Wirell S., Sunnegardh O., Ostberg P., and Osth L. Effects of contrast media on renal graft function and survival after cerebral angiography of cadaveric donors. Acta Radiol 30 (1989) 317
41. Toprak O., Cirit M., Yesil M., Byrne D.W., Postaci N., Bayata S., et al. Metabolic syndrome as a risk factor for contrast-induced nephropathy in non-diabetic elderly patients with renal impairment. Kidney Blood Press Res 29 (2006) 2
42. Andrade L., Campos S.B., and Seguro A.C. Hypercholesterolemia aggravates radiocontrast nephrotoxicity: protective role of arginine. Kidney Int 53 (1998) 1736
43. Khanal S., Attallah N., Smith D.E., Kline-Rogers E., Share D., O'Donnell M.J., et al. Statin therapy reduces contrast-induced nephropathy: an analysis of contemporary percutaneous interventions. Am J Med 118 (2005) 843
44. Babu A., and Fogelfeld L. Metabolic syndrome and prediabetes. Dis Mon 52 (2006) 55
45. Postlethwaite A.E., and Kelley W.N. Uricosuric effect of radiocontrast agents. A study in man of four commonly used preparations. Ann Intern Med 74 (1971) 845
46. Toprak O., Cirit M., Esi E., Postaci N., Yesil M., and Bayata S. Hyperuricemia as a risk factor for contrast-induced nephropathy in patients with chronic kidney disease. Catheter Cardiovasc Interv 67 (2006) 227
47. Toprak O., Cirit M., Bayata S., and Yesil M. Review of the radiocontrast nephropathy risk profiles and risk stratification. Anadolu Kardiyol Derg 4 (2004) 331
48. Kaur J.S., Goldberg J.P., and Schrier R.W. Acute renal failure following arteriography in a patient with polyarteritis nodosa. JAMA 247 (1982) 833
49. Vassiliu P., Sava J., Toutouzas K.G., and Velmahos G.C. Is contrast as bad as we think?. Renal function after angiographic embolization of injured patients. J Am Coll Surg 194 (2002) 142
50. Marenzi G., Lauri G., Assanelli E., Campodonico J., DeMetrio M., Marana I., et al. Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction. J Am Coll Cardiol 44 (2004) 1780